60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Stock Analysis

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is a publicly traded company in the HEALTHCARE sector. It trades at $1.47, carries a market capitalization of $3.88M. This page summarizes the public market data, fundamentals, and frequently asked questions for SXTP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.47
• Market Cap: $3.88M
• EPS: $-6.76
• 52-Week High: $14.68
• 52-Week Low: $1.29

Market Sentiment

60 Degrees Pharmaceuticals, Inc. Common Stock currently has a Bullish sentiment score of 0.34.

About 60 Degrees Pharmaceuticals, Inc. Common Stock

60 Degrees Pharmaceuticals, Inc. (SXTP) is a specialty pharmaceutical company focused on developing and commercializing innovative therapies aimed at preventing and treating infectious diseases. With a strategic emphasis on addressing unmet medical needs, the company leverages cutting-edge research to deliver effective treatment options in the global healthcare market. Headquartered in Washington, DC, 60 Degrees Pharmaceuticals is poised to make significant contributions to the field of infec...

GNG Research Analysis

GNG Research scores 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SXTP.

Frequently Asked Questions

Does SXTP pay dividends?

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) does not currently pay a regular dividend.

What is SXTP's market cap?

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a market capitalization of $3.88M with a current stock price of $1.47.